Analysts Are Bullish on Top Healthcare Stocks: HeartBeam (BEAT), Cresco Labs (CRLBF)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HeartBeam (BEAT – Research Report) and Cresco Labs (CRLBF – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
HeartBeam (BEAT)
In a report released today, Kyle Bauser from Roth MKM maintained a Buy rating on HeartBeam, with a price target of $4.00. The company’s shares closed last Thursday at $1.42.
According to TipRanks.com, Bauser has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on HeartBeam is a Strong Buy with an average price target of $5.83, implying a 269.0% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $5.50 price target.
See the top stocks recommended by analysts >>
Cresco Labs (CRLBF)
In a report released today, Neal Gilmer from Haywood reiterated a Buy rating on Cresco Labs, with a price target of C$2.00. The company’s shares closed last Thursday at $0.94.
According to TipRanks.com, Gilmer has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Cresco Labs.
